Navigation Links
Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
Date:1/24/2011

THOUSAND OAKS, Calif. and WOBURN, Mass., Jan. 24, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Group, Inc. today announced that the companies have entered into a definitive acquisition agreement under which Amgen has agreed to acquire BioVex Group, Inc., a privately held, venture-funded,  biotechnology company headquartered in Woburn, Mass. BioVex is developing OncoVEX(GM-CSF), a novel oncolytic vaccine in Phase 3 clinical development, that may represent a new approach to treating melanoma and head and neck cancer.

Under terms of the agreement, Amgen will pay up to $1 billion: $425 million in cash at closing and up to $575 million in additional payments upon the achievement of certain regulatory and sales milestones.  The transaction has been approved by the boards of directors of each company.  It is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2011.  Following the completion of the transaction, BioVex will become a wholly owned subsidiary of Amgen.  

"OncoVex has demonstrated encouraging anti-tumor activity in clinical studies for the treatment of melanoma and head and neck cancer, and BioVex is currently enrolling patients into pivotal Phase 3 trials in both indications," said Roger M. Perlmutter, M.D., Ph.D., Amgen's executive vice president, Research and Development.  "Amgen is particularly excited about joining with BioVex and its talented staff to focus on advancing this late-stage investigational therapy, with the hope of bringing it to market within the next few years."

"Amgen is ideally positioned to leverage the potential of OncoVEX in multiple solid tumor indications given their impressive oncology franchise and expertise in biologics manufacturing and development," said Philip Astley-Sparke, chi
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amgen and Xencor Enter Option Deal to Co-Develop Xencors Novel Antibody for Autoimmune Diseases
2. Call for Applications: The Amgen Award for Science Teaching Excellence
3. Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
4. Amgen to Provide Testimony at FDA Hearing on Biosimilars
5. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
6. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
7. Array BioPharma and Amgen Partner in Type 2 Diabetes
8. Amgen to Present at Lazard Capital Healthcare Conference
9. Amgen Announces Webcast of 2009 Third Quarter Financial Results
10. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
11. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014  China Cord Blood Corporation (NYSE: ... to release financial results for the first quarter of ... market close in the US.  The ... ET on Friday, August 29, 2014 to discuss its ... Company,s recent developments, followed by a question and answer ...
(Date:8/21/2014)... 21, 2014 Pursuit Solutions ( ... technology and services for Life Sciences sales and ... Use of New Commercial Sales Models” by Peter ... , The article examines some innovative models used ... being tested in the pharmaceutical market. Robinson grades ...
(Date:8/21/2014)... Louis, MO (PRWEB) August 21, 2014 ... full service biopharmaceutical contract development and manufacturing organization ... by Progenics Pharmaceuticals, Inc., an oncology company focused ... and treating cancer, to manufacture the anti-prostate specific ... PSMA ADC product candidate. Under the agreement ...
(Date:8/21/2014)... of last week RENU 28, the world's first and only ... purchase in Australia and New Zealand, and the response has ... if you think about the definition of aging, it's really ... your body. If you think about the definition of anti-aging, ... RENU 28 does is it works with these tiny little ...
Breaking Biology Technology:China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3RENU 28 Skin Care Now Available in Australia and New Zealand 2
... Kit produces cDNA , ideal for ... performed using real-time RT-PCR. The Cells-to-cDNA Kit comes in an , ... cells without RNA isolation in less than 2 ... Cell Lysis Buffer that inactivates RNases, RT-PCR can , ...
... , ... , Removes trace quantities of , ... RNase-free and recombinant in , ... lower in RNase activity than bovine pancreas , ...
... , ... , DNase enhancer increases the potency of TURBO DNase by ... , Remove DNase from RNA solutions in 5 minutes without phenol, alcohol, , ... TURBO DNase is RNase-free and recombinant in origin , The ...
Cached Biology Technology:Your Data: Detection of Oocyte-specific Gene Expression Using Ambion's Cells-to-cDNA Kit 2TURBO DNase: Hyperactive, Salt Tolerant DNase 2TURBO DNase: Hyperactive, Salt Tolerant DNase 3TURBO DNase: Hyperactive, Salt Tolerant DNase 4TURBO DNase: Hyperactive, Salt Tolerant DNase 5The World's Best DNase Improved TURBO DNA-free 2The World's Best DNase Improved TURBO DNA-free 3The World's Best DNase Improved TURBO DNA-free 4The World's Best DNase Improved TURBO DNA-free 5
(Date:8/21/2014)... a novel and versatile modeling strategy to simulate polyelectrolyte ... as well as for studying polyelectrolytes, including DNA and ... much larger and more complex polyelectrolyte systems, and to ... author of a paper on the work and a ... and Engineering. "This is a big step forward for ...
(Date:8/20/2014)... N.Y. In a study of 158 pregnant teenagers ... the craving and intentional consumption of ice, cornstarch, vacuum ... reports a new Cornell study. , Moreover, such teens ... who did not eat nonfood substances. , Pregnant teens, ... hemoglobin, which can lead to iron deficiency and anemia. ...
(Date:8/20/2014)... 20, 2014 /CNW/ -  Issue Serious ... quickly become life threatening for some children.    ... million Canadians have food allergies and this number may be ... children are estimated to have food allergies.  ... irritations and hives to breathing difficulties and loss of consciousness. ...
Breaking Biology News(10 mins):Researchers develop models to study polyelectrolytes, including DNA and RNA 2Pica in pregnant teens linked to low iron 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3
... new technique for turning embryonic stem cells into insulin-producing ... in the quest to find new treatments for diabetes. ... at the University of Sheffield, were able to genetically ... important protein known as a transcription factor. Stem ...
... camps atop glaciers in some of the most remote regions ... Branch at NASA,s Goddard Space Flight Center in Greenbelt, Md., ... Striking images taken by NASA satellites offer further visual evidence ... at the ends of the Earth. On Thursday, April ...
... Davis shows how our very short-term "working memory," which allows ... retains a limited number of high-resolution images for a few ... Humans rarely move their eyes smoothly. As our eyes flit ... to cut down visual "noise," said Steven J. Luck, professor ...
Cached Biology News:Stem cell breakthrough offers diabetes hope 2NASA expert to address Earth's vanishing polar ice, April 10, at UD 2Working memory has limited 'slots' 2